XML 33 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
OPERATING ACTIVITIES    
Net income $ 1,181 $ 114,670
Adjustments for non-cash items:    
Depreciation 53,801 47,807
Amortization 7,008 7,141
Stock-based compensation expense 13,974 13,435
Restructuring and asset impairment charges (Notes 7 and 18)) 17,708 (257)
Deferred income tax provision (13,750) 1,512
Loss on divestiture (Note 4) 6,517 0
Other 350 2,109
Changes in certain assets and liabilities:    
Accounts receivable 64,546 14,026
Inventories 34,329 (59,190)
Accounts Payable and accrued liabilities (28,548) (82,828)
Accrued income taxes (53,020) 7,995
Accrued pension and postretirement benefits (12,101) (9,760)
Other (4,898) 4,841
Net cash flow provided by operating activities 87,097 61,501
INVESTING ACTIVITIES    
Purchases of property, plant and equipment (147,532) (88,076)
Disposals of property, plant and equipment 835 2,490
Proceeds from divestiture (Note 4) 23,950 0
Other (922) 89
Net cash flow used for investing activities (123,669) (85,497)
FINANCING ACTIVITIES    
Net increase in notes payable 1,927 2,473
Net increase in short-term revolving and other lines of credit 0 (174)
Term debt repayments 0 (400,000)
Purchase of capital stock (106) (107)
The effect of employee benefit and stock plans and dividend reinvestment 5,583 2,182
Cash dividends paid to Shareholders (33,143) (32,820)
Other (1,779) 151
Net cash flow used for financing activities (38,684) (432,659)
Effect of exchange rate changes on cash and cash equivalents (1,549) (3,222)
CASH AND CASH EQUIVALENTS    
Net decrease in cash and cash equivalents (76,805) (459,877)
Cash and cash equivalents, beginning of period 182,015 556,153
Cash and cash equivalents, end of period $ 105,210 $ 96,276